MicuRx Pharmaceuticals Company
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
Headquarters:
Hayward, California, United States
Funding Status:
Late Stage Venture
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Small Molecules
Investor Type:
N/A
Founded Date:
2007
Industry:
PharmTech